Skip to main content
Caplight Logo









Augmedit

Augmedit

Private
NaardenHealthcare & Life Scienceshttps://www.augmedit.com/

Last Round

Seed

Nov 1, 2022

Total Funding Raised

$3.85M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Augmedit is a health technology company that develops medical augmented reality software to convert two-dimensional medical imaging into three-dimensional holographic models for surgical planning and intraoperative guidance.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, AR/VR Experiences, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

augmented reality surgerysurgical navigationneurosurgerysurgical visualizationmedical ARsoftware as a medical deviceSaMDintraoperative guidance3D holographic visualizationsurgical planninganatomical segmentationdigital surgerymedtechsurgical roboticsmedical imaging software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Augmedit Comparables

Compare Augmedit with similar companies based on industry and business-model similarity.

Augmedit comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medivis
86%
MediView XR, Inc.
79%
Surgical Theater
78%

Augmedit Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 1, 2022
GrantNov 1, 2022
GrantOct 9, 2020
SeedMar 30, 2020

Key People

Founding team and executive leadership

Tristan van Doormaal

Founder And Chief Medical Officer

Founding Team

Claartje Ypma

Founder CEO

Founding Team

Tom Mensink

Chief Technology Officer

Executive Team

Augmedit Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 29, 2026

    Grew 24% QoQ from 21 to 26 employees.

  • Dec 6, 2025

    Launched CE-marked Class IIb module for real-time placement of external ventricular drains.

Augmedit Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Augmedit Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Augmedit's valuation, stock price, and market status.

Firmographic Details

HeadquartersNaarden
Employee Range27
Year Founded2018
Last FundingNov 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?